150 related articles for article (PubMed ID: 16635614)
1. Use of breath carbon monoxide to measure the influence of prosthetic heart valves on erythrocyte survival.
Mitlyng BL; Chandrashekhar Y; Furne JK; Levitt MD
Am J Cardiol; 2006 May; 97(9):1374-6. PubMed ID: 16635614
[TBL] [Abstract][Full Text] [Related]
2. Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases.
Mitlyng BL; Singh JA; Furne JK; Ruddy J; Levitt MD
Am J Hematol; 2006 Jun; 81(6):432-8. PubMed ID: 16680757
[TBL] [Abstract][Full Text] [Related]
3. A simple carbon monoxide breath test to estimate erythrocyte turnover.
Strocchi A; Schwartz S; Ellefson M; Engel RR; Medina A; Levitt MD
J Lab Clin Med; 1992 Sep; 120(3):392-9. PubMed ID: 1517686
[TBL] [Abstract][Full Text] [Related]
4. Use of alveolar carbon monoxide to measure the effect of ribavirin on red blood cell survival.
Virtue MA; Furne JK; Ho SB; Levitt MD
Am J Hematol; 2004 Jun; 76(2):107-13. PubMed ID: 15164374
[TBL] [Abstract][Full Text] [Related]
5. Simplification of the end-alveolar carbon monoxide technique to assess erythrocyte survival.
Furne JK; Springfield JR; Ho SB; Levitt MD
J Lab Clin Med; 2003 Jul; 142(1):52-7. PubMed ID: 12878986
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of red blood cell destruction associated with valvular disease and prosthetic valves.
Wallace HW; Kenepp DL; Blakemore WS
J Thorac Cardiovasc Surg; 1970 Dec; 60(6):842-52. PubMed ID: 5488075
[No Abstract] [Full Text] [Related]
7. Mechanical versus bioprosthetic valve replacement in middle-aged patients.
Kulik A; Bédard P; Lam BK; Rubens FD; Hendry PJ; Masters RG; Mesana TG; Ruel M
Eur J Cardiothorac Surg; 2006 Sep; 30(3):485-91. PubMed ID: 16857373
[TBL] [Abstract][Full Text] [Related]
8. Multiple valve surgery with beating heart technique.
Ricci M; Macedo FI; Suarez MR; Brown M; Alba J; Salerno TA
Ann Thorac Surg; 2009 Feb; 87(2):527-31. PubMed ID: 19161773
[TBL] [Abstract][Full Text] [Related]
9. Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement.
Lund O; Bland M
J Thorac Cardiovasc Surg; 2006 Jul; 132(1):20-6. PubMed ID: 16798297
[TBL] [Abstract][Full Text] [Related]
10. Aortic and mitral valve replacement in children: is there any role for biologic and bioprosthetic substitutes?
Alsoufi B; Manlhiot C; McCrindle BW; Canver CC; Sallehuddin A; Al-Oufi S; Joufan M; Al-Halees Z
Eur J Cardiothorac Surg; 2009 Jul; 36(1):84-90; discussion 90. PubMed ID: 19369085
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular mass regression after aortic valve replacement with the new Mitroflow 12A pericardial bioprosthesis.
García-Bengochea J; Sierra J; González-Juanatey JR; Rubio J; Vega M; Fernández AL; Sánchez D
J Heart Valve Dis; 2006 May; 15(3):446-51; discussion 451-2. PubMed ID: 16784087
[TBL] [Abstract][Full Text] [Related]
12. Aortic valve replacement: choice between mechanical valves and bioprostheses.
Silberman S; Oren A; Dotan M; Merin O; Fink D; Deeb M; Bitran D
J Card Surg; 2008; 23(4):299-306. PubMed ID: 18462345
[TBL] [Abstract][Full Text] [Related]
13. Surgical management of aortic valve disease in the elderly: A retrospective comparative study of valve choice using propensity score analysis.
Accola KD; Scott ML; Palmer GJ; Thompson PA; Sand ME; Suarez-Cavalier JE; Bott JN; Ebra G
J Heart Valve Dis; 2008 Jul; 17(4):355-64; discussion 365. PubMed ID: 18751463
[TBL] [Abstract][Full Text] [Related]
14. Estimation of red blood cell lifespan from alveolar carbon monoxide measurements.
Krishnan SM; Dixit NM
Transl Res; 2009 Jul; 154(1):15-7. PubMed ID: 19524869
[TBL] [Abstract][Full Text] [Related]
15. Which valve and which size should we use in the valve-on-valve technique for re-do mitral valve surgery?
Shibata T; Inoue K; Ikuta T; Bito Y; Yoshioka Y; Mizoguchi H
Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):206-10. PubMed ID: 19010939
[TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline treatment for microangiopathic hemolytic anemia caused by mechanical heart valves.
Geller S; Gelber R
Md Med J; 1999; 48(4):173. PubMed ID: 10461440
[TBL] [Abstract][Full Text] [Related]
17. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.
Yeghiazaryan K; Skowasch D; Bauriedel G; Schild H; Golubnitschaja O
Amino Acids; 2007 Jan; 32(1):109-14. PubMed ID: 16874466
[TBL] [Abstract][Full Text] [Related]
18. Reduced membrane sialic acid contents of the erythrocytes after heart valve replacement with prosthetic devices.
Ricci G; Martinelli L; Viganò M; Strozzi C
Biomed Pharmacother; 1986; 40(1):25-7. PubMed ID: 3708116
[TBL] [Abstract][Full Text] [Related]
19. St Jude Epic heart valve bioprostheses versus native human and porcine aortic valves - comparison of mechanical properties.
Kalejs M; Stradins P; Lacis R; Ozolanta I; Pavars J; Kasyanov V
Interact Cardiovasc Thorac Surg; 2009 May; 8(5):553-6. PubMed ID: 19190025
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic performance of the new St. Jude Medical Epic Supra porcine bioprosthesis in comparison to the Medtronic Mosaic on the basis of patient annulus diameter.
Ruzicka DJ; Eichinger WB; Hettich IM; Bleiziffer S; Bauernschmitt R; Lange R
J Heart Valve Dis; 2008 Jul; 17(4):426-33; discussion 434. PubMed ID: 18751473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
